Novavax Inc, a Biotechnology firm and Serum Institute of India announced that they have received the first emergency use authorization for the COVID-19 vaccine in Indonesia.
Highlights
• Novavax’s Covid-19 vaccine receives EUA
• The product will be marketed as Covovax,
Serum Institut....
Tags : COVID-19 vaccine, Indonesia, Novavax, Serum Institute,
comments (0)